Massachusetts Institute of Technology
Sign in | Create Account

From Lab to Market: Where Technology is Headed

09/29/2004 9:45 AM Kresge
Rebecca M. Henderson, '81, Eastman Kodak LFM Professor of Management; Paul Horn, Senior Vice President and Director; IBM Research ; Uma Chowdhry, PhD '76, Vice President, Global Central Research and Development; DuPont ; ; Robert Tepper, President, Research and Development ; Millennium Pharmaceuticals

Description: How do you conduct R&D in a vanguard technology? These three panelists provide varying perspectives on the question. Paul Horn stands by IBM's longstanding commitment to its 5.5 billion dollar annual research effort, but with some caveats: "It's all about the speed of flowing new ideas into hardware, software and services," he says. You can't think about innovation without also considering "channels to market." IBM insists that "researchers spend time in the marketplace so they can understand how their technology can solve real world problems."

At DuPont, Uma Chowdhry cites a "quietly occurring transformation in the area of biobased materials." At two centuries' young, DuPont has a new primary challenge: "How do we transform from a petroleum-based economy to renewable resources such as crops?" Working with partners such as MIT, the company is exploring glucose, methane and nanotechnology to cook up new kinds of fuel, food supplements, and other products all economically. It's "a very big dream," acknowledges Chowdhry. The prerequisite, she says, is that "top management must have an unwavering commitment to the mission as well as time, vision and patience."

Robert Tepper describes the convergence of two revolutions driving his field forward. The complete sequencing of the human genome, combined with advances in understanding pathways of disease, will enable Millennium's researchers to create "breakthrough therapies." Scientists are already "making strides in cancer and inflammation," says Tepper. Millennium is linking up with industry, hospitals and academia, plumbing the genome to learn "why individuals are susceptible to disease."

Host(s): Office of the Provost, Technology Review

Tape #: 19004

Comments (0)

It looks like no one has posted a comment yet. You can be the first!

You need to log in, in order to post comments. If you don’t have an account yet, sign up now!

MIT World — special events and lectures

MIT World — special events and lectures

Category: Events | Updated almost 3 years ago

Created
December 12, 2011 19:31
Category
Tags
License
All Rights Reserved (What is this?)
Additional Files


Viewed
2220 times

More from MIT World — special events and lectures

The Akamai Story: From Theory to Practice

The Akamai Story: From Theory to Pr...

Added almost 3 years ago | 00:55:42 | 2440 views

The Future of Civic Engagement in a Broadband"Enabled World

The Future of Civic Engagement in a...

Added almost 3 years ago | 00:35:08 | 3751 views

Doing R&D Smarter: A More Effective Approach to Industrial R&D

Doing R&D Smarter: A More Effective...

Added almost 3 years ago | 01:10:00 | 1412 views

Warning: Physics Envy May be Hazardous to Your Wealth

Warning: Physics Envy May be Hazard...

Added almost 3 years ago | 00:57:18 | 7463 views

Not Your Typical CEO

Not Your Typical CEO

Added almost 3 years ago | 00:54:06 | 1870 views

Innovation Spotlight: Bringing Children's Media off the Screen

Innovation Spotlight: Bringing Chil...

Added almost 3 years ago | 00:27:04 | 3891 views